About RenovoRx Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://renovorx.com/
Frequently Asked Questions
What is the 52-week range for RNXT?
The 52-week high is $2.59 and the 52-week low is $0.7006.
What is the P/E ratio for RNXT?
The P/E ratio data is currently unavailable.
What is the dividend yield for RNXT?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -145.63%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -621.71%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 5.68.
Analyst Recommendation Trends
Wall Street analyst consensus for RNXT over the last few months:
Latest RNXT News
RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
Case Series Reports Tumor Treatment Response, Significant Tumor Marker Reduction, and Changes on Imaging After Treatment with TAMP in Patients with Unresectable LAPCMOUNTAIN VIEW, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced the publication of a peer-reviewed case series i
RenovoRx Announces Publication Of Peer-Reviewed Case Series In Case Reports In Oncology From Researchers At Hackensack Meridian Health’s Jersey Shore University Medical Center
RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-10-01 | Macfarlane K. Angela | +55,924 | - | - |
| 2026-10-01 | Marton Laurence | +55,924 | - | - |
| 2026-10-01 | Spiegel Robert J. | +55,924 | - | - |
| 2026-10-01 | RYAN UNA S | +55,924 | - | - |
| 2026-09-10 | VOLL MARK | +80,000 | - | - |
| 2026-05-19 | VOLL MARK | +25,000 | $0.7876 | $19,690 |
| 2026-04-03 | Bagai Shaun | +946,107 | - | - |
| 2026-04-03 | Gentry Leesa | +128,550 | - | - |
| 2026-04-03 | Agah Ramtin | +621,727 | - | - |
| 2026-04-03 | VOLL MARK | +80,000 | - | - |
| 2026-03-25 | VOLL MARK | +12,380 | - | - |
| 2026-03-20 | Marton Laurence | +4,860 | - | - |
| 2026-03-20 | Marton Laurence | +9,720 | - | - |
| 2026-03-20 | Bagai Shaun | +12,150 | - | - |
| 2026-03-20 | Bagai Shaun | +24,300 | - | - |
| 2026-03-20 | VOLL MARK | +48,600 | - | - |
| 2026-03-20 | VOLL MARK | +97,200 | - | - |
| 2026-01-21 | Agah Ramtin | +10,000 | $0.9975 | $9,975 |
| 2025-12-31 | Agah Ramtin | +9,795 | $0.86 | $8,424 |
| 2025-12-30 | Agah Ramtin | +205 | $0.826 | $169 |
| 2025-12-18 | Bagai Shaun | +5,000 | $0.9013 | $4,507 |
| 2025-12-17 | Bagai Shaun | +5,000 | $0.8524 | $4,262 |
| 2025-12-16 | Agah Ramtin | +12,000 | $0.85 | $10,200 |
| 2025-12-05 | Agah Ramtin | +10,000 | $0.96 | $9,600 |
| 2025-11-24 | Agah Ramtin | +12,000 | $0.8 | $9,600 |
| 2025-11-21 | Agah Ramtin | +10,000 | $0.8 | $8,000 |